Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
sumatriptan
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 1991 |
| gptkbp:ATCCode |
N02CC01
|
| gptkbp:chemicalClass |
triptan
|
| gptkbp:contraindication |
ischemic heart disease
uncontrolled hypertension |
| https://www.w3.org/2000/01/rdf-schema#label |
Imigran
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:routeOfAdministration |
oral
nasal spray subcutaneous injection |
| gptkbp:sideEffect |
dizziness
tingling drowsiness flushing |
| gptkbp:usedFor |
migraine
cluster headache |
| gptkbp:bfsParent |
gptkb:Glaxo_Wellcome
|
| gptkbp:bfsLayer |
7
|